Advertisement
Screener

EXAGEN INC. (XGN) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

EXAGEN INC. Investing Cash Flow

EXAGEN INC. (XGN) reported Investing Cash Flow of -$771.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-04

  • EXAGEN INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$543.00K.
  • EXAGEN INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$228.00K.
  • EXAGEN INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$35.00K.
  • EXAGEN INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$275.00K.
  • EXAGEN INC. net cash provided by (used in) investing activities for fiscal 2025 was -$626.00K.
  • EXAGEN INC. net cash provided by (used in) investing activities for fiscal 2024 was -$515.00K.
  • EXAGEN INC. net cash provided by (used in) investing activities for fiscal 2023 was -$804.00K.
  • EXAGEN INC. net cash provided by (used in) investing activities for fiscal 2022 was -$4.32M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30-$543.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$771.00K
10-Q · filed 2026-08-04
-$806.00K
derived: sum of 3 quarters · filed 2026-08-04
-$1.08M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$228.00K
10-Q · filed 2026-05-11
-$263.00K
derived: sum of 2 quarters · filed 2026-05-11
-$538.00K
derived: sum of 3 quarters · filed 2026-05-11
-$747.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$35.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
-$310.00K
derived: sum of 2 quarters · filed 2026-03-10
-$519.00K
derived: sum of 3 quarters · filed 2026-08-04
-$626.00K
10-K · filed 2026-03-10
2025-09-30-$275.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$484.00K
derived: sum of 2 quarters · filed 2026-08-04
-$591.00K
10-Q · filed 2025-11-04
-$737.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$209.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$316.00K
10-Q · filed 2026-08-04
-$462.00K
derived: sum of 3 quarters · filed 2026-08-04
-$609.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$107.00K
10-Q · filed 2026-05-11
-$253.00K
derived: sum of 2 quarters · filed 2026-05-11
-$400.00K
derived: sum of 3 quarters · filed 2026-05-11
-$536.00K
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31-$146.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
-$293.00K
derived: sum of 2 quarters · filed 2026-03-10
-$429.00K
derived: sum of 3 quarters · filed 2026-03-10
-$515.00K
10-K · filed 2026-03-10
2024-09-30-$147.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$283.00K
derived: sum of 2 quarters · filed 2025-11-04
-$369.00K
10-Q · filed 2025-11-04
-$453.00K
derived: sum of 4 quarters · filed 2025-11-04
2024-06-30-$136.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
-$222.00K
10-Q · filed 2025-07-29
-$306.00K
derived: sum of 3 quarters · filed 2025-07-29
-$308.00K
derived: sum of 4 quarters · filed 2025-07-29
2024-03-31-$86.00K
10-Q · filed 2025-05-05
-$170.00K
derived: sum of 2 quarters · filed 2025-05-05
-$172.00K
derived: sum of 3 quarters · filed 2025-05-05
-$494.00K
derived: sum of 4 quarters · filed 2025-05-05
2023-12-31-$84.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
-$86.00K
derived: sum of 2 quarters · filed 2025-03-11
-$408.00K
derived: sum of 3 quarters · filed 2025-03-11
-$804.00K
10-K · filed 2025-03-11
2023-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$324.00K
derived: sum of 2 quarters · filed 2024-11-12
-$720.00K
10-Q · filed 2024-11-12
-$1.13M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$322.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
-$718.00K
10-Q · filed 2024-08-05
-$1.12M
derived: sum of 3 quarters · filed 2024-08-05
-$2.00M
derived: sum of 4 quarters · filed 2024-08-05
2023-03-31-$396.00K
10-Q · filed 2024-05-13
-$802.00K
derived: sum of 2 quarters · filed 2024-05-13
-$1.68M
derived: sum of 3 quarters · filed 2024-05-13
-$3.63M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$406.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18
-$1.28M
derived: sum of 2 quarters · filed 2024-03-18
-$3.23M
derived: sum of 3 quarters · filed 2024-03-18
-$4.32M
10-K · filed 2024-03-18
2022-09-30-$879.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$2.83M
derived: sum of 2 quarters · filed 2023-11-13
-$3.91M
10-Q · filed 2023-11-13
-$4.98M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$1.95M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
-$3.03M
10-Q · filed 2023-08-07
-$4.10M
derived: sum of 3 quarters · filed 2023-08-07
-$4.57M
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31-$1.09M
10-Q · filed 2023-05-15
-$2.15M
derived: sum of 2 quarters · filed 2023-05-15
-$2.63M
derived: sum of 3 quarters · filed 2023-05-15
-$3.34M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20
-$1.54M
derived: sum of 2 quarters · filed 2023-03-20
-$2.25M
derived: sum of 3 quarters · filed 2023-03-20
-$2.42M
10-K · filed 2023-03-20
2021-09-30-$475.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21
-$1.19M
derived: sum of 2 quarters · filed 2022-11-21
-$1.36M
10-Q · filed 2022-11-21
-$1.36M
derived: sum of 4 quarters · filed 2022-11-21
2021-06-30-$714.00K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-11-21
-$881.00K
10-Q/A · filed 2022-11-21
-$886.00K
derived: sum of 3 quarters · filed 2022-11-21
-$1.10M
derived: sum of 4 quarters · filed 2022-11-21
2021-03-31-$167.00K
10-Q · filed 2022-05-11
-$172.00K
derived: sum of 2 quarters · filed 2022-05-11
-$385.00K
derived: sum of 3 quarters · filed 2022-05-11
-$538.00K
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31-$5.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22
-$218.00K
derived: sum of 2 quarters · filed 2022-03-22
-$371.00K
derived: sum of 3 quarters · filed 2022-03-22
-$455.00K
10-K · filed 2022-03-22
2020-09-30-$213.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
-$366.00K
derived: sum of 2 quarters · filed 2021-11-10
-$450.00K
10-Q · filed 2021-11-10
-$476.00K
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$153.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$237.00K
10-Q · filed 2021-08-09
-$263.00K
derived: sum of 3 quarters · filed 2021-08-09
-$265.00K
derived: sum of 4 quarters · filed 2021-08-09
2020-03-31-$84.00K
10-Q · filed 2021-05-11
-$110.00K
derived: sum of 2 quarters · filed 2021-05-11
-$112.00K
derived: sum of 3 quarters · filed 2021-05-11
$176.00K
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31-$26.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
-$28.00K
derived: sum of 2 quarters · filed 2021-03-16
$260.00K
derived: sum of 3 quarters · filed 2021-03-16
-$103.00K
10-K · filed 2021-03-16
2019-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
$286.00K
derived: sum of 2 quarters · filed 2020-11-10
-$77.00K
10-Q · filed 2020-11-10
$852.00K
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30$288.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28
-$75.00K
10-Q · filed 2020-07-28
$854.00K
derived: sum of 3 quarters · filed 2020-07-28
2019-03-31-$363.00K
10-Q · filed 2020-05-11
$566.00K
derived: sum of 2 quarters · filed 2020-05-11
2018-12-31$929.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25
-$199.00K
10-K · filed 2020-03-25
2018-09-30-$1.13M
10-Q · filed 2019-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Freenome, Inc. (FRNM)United States$0.143B
BIODESIX INC (BDSX)United States$0.312B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45